WEBINARS
prev
next
SYMBYX IN THE MEDIA

11/01/23

Parkinson's News Today

Gains Seen in Parkinson's with Symbyx's Red Light Therapy Helmet. Symbyx Neuro uses a 12-minute cycle of red light therapy followed by 12 minutes of infrared light therapy. Improvement was seen across measures of facial expression, upper limb, walking, and tremor.

Read More
PRESS RELEASES
prev
SYMBYX announces promising SAN clinical trial results for Parkinson’s using the SYMBYX Neuro - the new red light therapy helmet
SYMBYX light therapy in 5 abstracts presented at the World Parkinson's Congress 2023
TWO NEW CLINICAL TRIALS
Mater Research leads world-first trial for bowel disease
SYMBYX announces start of ground-breaking Parkinson’s light therapy trial in Canada
SYMBYX company closes A-Round funding, May 2021
next

Explore our range of next generation light therapy

SHOP ALL